Tyra Biosciences
  • Our Approach
  • Pipeline & Targets
  • Our People
  • Patients
  • For Investors
Select Page
Leslie Aguilar

Leslie Aguilar

by jen@juniper-point.com | Mar 7, 2025

Caleb Frye

Caleb Frye

by jen@juniper-point.com | Mar 4, 2025

Xin Huang

Xin Huang

by jen@juniper-point.com | Mar 3, 2025

Sinette Heys

Sinette Heys

by jen@juniper-point.com | Mar 3, 2025

Stephanie Pierpoint

Stephanie Pierpoint

by amyconrad | Jan 21, 2025

« Older Entries
Next Entries »

Recent News

  • Tyra Biosciences raises $106M in Series B financing to advance novel pipeline of therapies targeting acquired resistance in oncology
  • Tyra Biosciences raises $50M to develop therapies targeting acquired resistance in oncology

Categories

  • Fundraising
  • Contact
  • Terms & Conditions
  • Privacy Policy
© Copyright 2025 Tyra Biosciences, Inc. Site Design